相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Piperaquine Pharmacokinetics during Intermittent Preventive Treatment for Malaria in Pregnancy
Palang Chotsiri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi
Steve M. Taylor et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis
Michelle E. Roh et al.
LANCET GLOBAL HEALTH (2020)
Modelling the incremental benefit of introducing malaria screening strategies to antenatal care in Africa
Patrick G. T. Walker et al.
NATURE COMMUNICATIONS (2020)
Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs
Makoto Saito et al.
Lancet Child & Adolescent Health (2020)
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial
Richard Kajubi et al.
LANCET (2019)
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis
Anna Maria van Eijk et al.
LANCET INFECTIOUS DISEASES (2019)
Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation
Claire D. Bourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial
Rukhsana Ahmed et al.
LANCET INFECTIOUS DISEASES (2019)
Composition of the gut microbiota transcends genetic determinants of malaria infection severity and influences pregnancy outcome
Catherine D. Morffy Smith et al.
EBIOMEDICINE (2019)
Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study
Robyn E. Elphinstone et al.
PLOS MEDICINE (2019)
Likelihood-based random-effects meta-analysis with few studies: empirical and simulation studies
Svenja E. Seide et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
Effects of Malaria in the First Trimester of Pregnancy on Poor Maternal and Birth Outcomes in Benin
Manfred Accrombessi et al.
CLINICAL INFECTIOUS DISEASES (2019)
Prevention of malaria in pregnancy
Meghna Desai et al.
LANCET INFECTIOUS DISEASES (2018)
Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria
Ekpereonne Esu et al.
MALARIA JOURNAL (2018)
Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial
Titus H. Divala et al.
LANCET INFECTIOUS DISEASES (2018)
Intermittent screening and treatment or intermittent preventive treatment compared to current policy of single screening and treatment for the prevention of malaria in pregnancy in Eastern Indonesia: acceptability among health providers and pregnant women
Jenna Hoyt et al.
MALARIA JOURNAL (2018)
Dosage of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in a Cohort of Zambian Pregnant Women in a Low Malaria Prevalence Region
Marie C. D. Stoner et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission
Kerryn A. Moore et al.
BMC MEDICINE (2017)
Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections
R. Matthew Chico et al.
CLINICAL INFECTIOUS DISEASES (2017)
Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight
Meghna Desai et al.
CLINICAL INFECTIOUS DISEASES (2016)
Stillbirths: rates, risk factors, and acceleration towards 2030
Joy E. Lawn et al.
LANCET (2016)
Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial
Silke Fernandes et al.
MALARIA JOURNAL (2016)
Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi
Deborah Almond et al.
MALARIA JOURNAL (2016)
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy
Abel Kakuru et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial
Mwayiwawo Madanitsa et al.
PLOS MEDICINE (2016)
User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya
Jenny Hill et al.
PLOS ONE (2016)
Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial
Joshua Kimani et al.
PLOS ONE (2016)
The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women
Julie Gutman et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial
Meghna Desai et al.
LANCET (2015)
A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy
Harry Tagbor et al.
PLOS ONE (2015)
Two-stage individual participant data meta-analysis and generalized forest plots
David J. Fisher
STATA JOURNAL (2015)
International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project
Jose Villar et al.
LANCET (2014)
The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana
Christopher Pell et al.
MALARIA JOURNAL (2014)
Intermittent Preventive Therapy for Malaria During Pregnancy Using 2 vs 3 or More Doses of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in Africa Systematic Review and Meta-analysis
Kassoum Kayentao et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria
Inbarani Naidoo et al.
TRENDS IN PARASITOLOGY (2013)
Plasmodium falciparum Mutant Haplotype Infection during Pregnancy Associated with Reduced Birthweight, Tanzania
Daniel T. R. Minja et al.
EMERGING INFECTIOUS DISEASES (2013)
The Malaria in Pregnancy Library: a bibliometric review
Anna M. van Eijk et al.
MALARIA JOURNAL (2012)
Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study
Jennifer B. Griffin et al.
MALARIA JOURNAL (2012)
Intermittent Treatment to Prevent Pregnancy Malaria Does Not Confer Benefit in an Area of Widespread Drug Resistance
Whitney E. Harrington et al.
CLINICAL INFECTIOUS DISEASES (2011)
Intermittent Screening and Treatment versus Intermittent Preventive Treatment of Malaria in Pregnancy: Provider Knowledge and Acceptability
Lucy Smith Paintain et al.
PLOS ONE (2011)
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability
Lucy A. Smith et al.
MALARIA JOURNAL (2010)
Intermittent Screening and Treatment versus Intermittent Preventive Treatment of Malaria in Pregnancy: A Randomised Controlled Non-Inferiority Trial
Harry Tagbor et al.
PLOS ONE (2010)
Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment
W. E. Harrington et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Methods for estimating adjusted risk ratios
Peter Cummings
STATA JOURNAL (2009)
A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana
Christine Alexandra Clerk et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Epidemiology and burden of malaria in pregnancy
Meghna Desai et al.
LANCET INFECTIOUS DISEASES (2007)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
